Back to Trades
Azelby Robert
DirectorCIK 0001656998
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 5
- Active
- 2025–2026
Azelby Robert, Director, has filed 8 SEC reports (2025–2026), spread across 5 companies, totaling $1.6M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Jul 1 | AUTL Autolus Therapeutics plc | Azelby Robert | Director | Award | $76.5K |
| Jun 23 | TNGX Tango Therapeutics, Inc. | Azelby Robert | Insider | Grant | $1.0M |
| Jun 23 | TNGX Tango Therapeutics, Inc. | Azelby Robert | Insider | Other | $0 |
| Jun 3 | ADCT ADC Therapeutics SA | Azelby Robert | Director | Grant | $38.8K |
| May 5 | TERN Terns Pharmaceuticals, Inc. | Azelby Robert | Insider | Disposed | $430.4K |
| Mar 18 | AUTL Autolus Therapeutics plc | Azelby Robert | Insider | Other | $0 |
| Feb 2 | TERN Terns Pharmaceuticals, Inc. | Azelby Robert | Insider | Award | $58.7K |
| Nov 6 | CAH CARDINAL HEALTH INC | Azelby Robert | Director | Grant | $0 |
8 filings